Catabolic hormones and growth hormone resistance in acquired immunodeficiency syndrome and other catabolic states.
Rodgers
B D
BD
Group in Endocrinology, University of California, Berkeley 94720, USA.
D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology*; D000818:Animals; D002100:Cachexia / Q000503:physiopathology; D003922:Diabetes Mellitus, Type 1 / Q000503:physiopathology; D004351:Drug Resistance / Q000502:physiology; D004702:Endocrine Glands / Q000503:physiopathology; D005215:Fasting / Q000502:physiology; D005938:Glucocorticoids / Q000502:physiology; D006128:Growth / Q000502:physiology; D013006:Growth Hormone / Q000502:physiology*; D006728:Hormones / Q000502:physiology*; D006801:Humans; D007108:Immune Tolerance / Q000502:physiology; D007334:Insulin-Like Growth Factor I / Q000502:physiology; D011502:Protein-Energy Malnutrition / Q000503:physiopathology; D014947:Wounds and Injuries / Q000503:physiopathology
D005938:Glucocorticoids; D006728:Hormones; D007334:Insulin-Like Growth Factor I; D013006:Growth Hormone